niraparib 100 mg Pill - purple white capsule/oblong, 22mm
Generic Name: niraparib
Pill with imprint niraparib 100 mg is Purple / White, Capsule/Oblong and has been identified as Zejula 100 mg. It is supplied by Tesaro Inc.
Zejula is used in the treatment of Ovarian Cancer; Peritoneal Cancer; Fallopian Tube Cancer and belongs to the drug class PARP inhibitors. Zejula 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for niraparib 100 mg
Zejula
- Generic Name
- niraparib
- Imprint
- niraparib 100 mg
- Strength
- 100 mg
- Color
- Purple / White
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- PARP inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Tesaro Inc.
- National Drug Code (NDC)
- 69656-0103 (Discontinued)
- Inactive Ingredients
-
magnesium stearate,
lactose monohydrate,
titanium dioxide,
gelatin hydrolysate (porcine skin, mw 3000),
FD&C Blue No. 1,
FD&C Red No. 3,
FD&C Yellow No. 5
Note: Inactive ingredients may vary.
More about Zejula (niraparib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (58)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: PARP inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.